EUVIMEDEUVIMED entdecken
Crossref

A [68Ga]-labeled PDGFRβ-targeting peptide PET probe for assessing MASH-related fibrosis in diet-induced preclinical models and human liver specimens

Chao Tang, Huanhuan Song, Qian Zhu, Pengzhe Han, Mengqi Wang, Xuchen Zhao, Nannan Chen, Xueqin Liu, Congzhong Hu, Xiaolong Li, Xifeng Fu, Raymond T Chung und 4 weitere

Biochemical Pharmacology · 2026-10 · 252 · 118205

DOI: 10.1016/j.bcp.2026.118205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-10. Verfasst von Chao Tang und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China; J…. Hauptthemen laut MEDLINE: Receptor, Platelet-Derived Growth Factor beta, Gallium Radioisotopes, Liver Cirrhosis, Liver. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by hepatocellular injury, inflammation, and progressive fibrosis, yet current non-invasive tests do not directly assess the cellular drivers of fibrogenesis. Platelet-derived growth factor receptor beta (PDGFRβ) is highly expressed on activated hepatic stellate cells (aHSC), a major effector cell population in MASH. A PDGFRβ-targeted peptide was synthesized and radiolabeled with gallium-68. We investigated whether PDGFRβ-targeted PET imaging could enable non-invasive molecular assessment of MASH severity. Dynamic PET/CT, ex vivo autoradiography, histopathology, immunostaining, western blotting, and qPCR were performed in graded MASH mouse models induced by choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) and methionine-choline-deficient (MCD) diet, with human MASH liver specimens for validation. Both CDAHFD and MCD models developed progressive steatohepatitis and fibrosis accompanied by increasing hepatic PDGFRβ expression. PDGFRβ colocalized with αSMA positive aHSC populations and the proportion of PDGFRβ/αSMA double positive cells increased markedly in diseased livers. PET imaging demonstrated progressively increased hepatic uptake of the 68Ga-labeled PDGFRβ probe with worsening disease severity in both models. Probe uptake quantified by SUV and AUC paralleled histological fibrosis, PDGFRβ protein expression, and fibrosis-related gene transcription. Autoradiography confirmed specific probe binding in mouse liver sections. In human MASH specimens, PDGFRβ expression and probe binding similarly increased with pathological severity and correlated with fibrosis-associated markers. PDGFRβ-targeted PET imaging enables non-invasive molecular visualization of aHSC and provides a quantitative imaging approach for grading MASH severity. These findings support PDGFRβ as a candidate imaging biomarker for biologically active fibrogenesis in MASH and provide a rationale for future clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Platelet-Derived Growth Factor betaGallium RadioisotopesLiver CirrhosisLiverDiet, High-FatPeptidesPositron Emission Tomography Computed TomographyAnimalsHumansMiceMaleMice, Inbred C57BLPositron-Emission TomographyHepatic Stellate Cells

Stichwörter der Autor:innen

Activated hepatic stellate cellsMetabolic dysfunction-associated steatohepatitisMolecular PET imagingPDGFRβ

Substanzen

Receptor, Platelet-Derived Growth Factor betaGallium RadioisotopesGallium-68PDGFRB protein, humanPeptides

Autor:innen und Institutionen

  • The Second Affiliated Hospital, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China; Jiangsu Key Laboratory of Infection and Immunity, Soochow University, S…
  • Department of Biliary and Pancreatic Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.
  • The Second Affiliated Hospital, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China.
  • Liver Center, Massachusetts General Hospital, GI Division, Mass General Brigham, Boston, MA, USA.
  • Department of Radiology and Imaging Sciences, Emory University, Atlanta, USA.
  • The Second Affiliated Hospital, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China. Electronic address: zjpei@suda.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Tang, C., Song, H., Zhu, Q., Han, P., Wang, M., Zhao, X., Chen, N., Liu, X., Hu, C., Li, X., Fu, X., Chung, R. T., Liang, S., Pei, Z., Tian, Y., & Shao, T. (2026). A [68Ga]-labeled PDGFRβ-targeting peptide PET probe for assessing MASH-related fibrosis in diet-induced preclinical models and human liver specimens. Biochemical Pharmacology, 252, 118205. https://doi.org/10.1016/j.bcp.2026.118205

Vancouver

Tang C, Song H, Zhu Q, Han P, Wang M, Zhao X, et al. A [68Ga]-labeled PDGFRβ-targeting peptide PET probe for assessing MASH-related fibrosis in diet-induced preclinical models and human liver specimens. Biochemical Pharmacology. 2026;252:118205. doi:10.1016/j.bcp.2026.118205

BibTeX
@article{Tang2026,
  author = {Tang, Chao and Song, Huanhuan and Zhu, Qian and Han, Pengzhe and Wang, Mengqi and Zhao, Xuchen and Chen, Nannan and Liu, Xueqin and Hu, Congzhong and Li, Xiaolong and Fu, Xifeng and Chung, Raymond T and Liang, Steven and Pei, Zhijun and Tian, Yanzhang and Shao, Tuo},
  title = {A [68Ga]-labeled PDGFRβ-targeting peptide PET probe for assessing MASH-related fibrosis in diet-induced preclinical models and human liver specimens},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {252},
  pages = {118205},
  doi = {10.1016/j.bcp.2026.118205}
}
Kostenlos starten →